BeyondSpring Inc. cotiza a 0.61 USD y tiene una capitalización bursátil de $25M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company's lead asset is Plinabulin, a selective imm…
| Periodo | 2026-08 | 2022-04 | 2021-12 | 2021-09 |
|---|---|---|---|---|
| Real | — | $-0.24 | $-0.47 | $-0.49 |
| Estimado | — | $-0.22 | $-0.30 | $-0.29 |
| Sorpresa | — | -9.1% | -56.7% | -69.0% |
| Métrica | BYSI | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | -3.9% | -32.0% | +28.1% |
| Current Ratio | 1.54 | 2.84 | -1.30 |
| Debt / Equity | — | 0.28 | — |